Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS by Jarmusch, Alan K. et al.
Lipid and metabolite profiles of human brain tumors by
desorption electrospray ionization-MS
Alan K. Jarmuscha, Valentina Pirroa, Zane Bairda, Eyas M. Hattabb, Aaron A. Cohen-Gadolc, and R. Graham Cooksa,1
aDepartment of Chemistry and Center for Analytical Instrumentation Development, Purdue University, West Lafayette, IN 47907; bDepartment of Pathology
and Laboratory Medicine, Indiana School of Medicine, Indianapolis, IN 46202; and cDepartment of Neurological Surgery, Indiana University School of
Medicine, Indianapolis, IN 46202
This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2015.
Contributed by R. Graham Cooks, December 21, 2015 (sent for review November 24, 2015; reviewed by Richard N. Zare and Arash Zarrine-Afsar)
Examination of tissue sections using desorption electrospray
ionization (DESI)-MS revealed phospholipid-derived signals that
differ between gray matter, white matter, gliomas, meningiomas,
and pituitary tumors, allowing their ready discrimination by multi-
variate statistics. A set of lower mass signals, some corresponding
to oncometabolites, including 2-hydroxyglutaric acid and N-acetyl-
aspartic acid, was also observed in the DESI mass spectra, and these
data further assisted in discrimination between brain parenchyma
and gliomas. The combined information from the lipid and metab-
olite MS profiles recorded by DESI-MS and explored using multivar-
iate statistics allowed successful differentiation of gray matter (n =
223), white matter (n = 66), gliomas (n = 158), meningiomas (n =
111), and pituitary tumors (n = 154) from 58 patients. A linear dis-
criminant model used to distinguish brain parenchyma and gliomas
yielded an overall sensitivity of 97.4% and a specificity of 98.5%.
Furthermore, a discriminant model was created for tumor types (i.e.,
glioma, meningioma, and pituitary), which were discriminated with
an overall sensitivity of 99.4% and a specificity of 99.7%. Unsuper-
vised multivariate statistics were used to explore the chemical dif-
ferences between anatomical regions of brain parenchyma and
secondary infiltration. Infiltration of gliomas into normal tissue
can be detected by DESI-MS. One hurdle to implementation of
DESI-MS intraoperatively is the need for tissue freezing and section-
ing, which we address by analyzing smeared biopsy tissue. Tissue
smears are shown to give the same chemical information as tissue
sections, eliminating the need for sectioning before MS analysis.
These results lay the foundation for implementation of intraopera-
tive DESI-MS evaluation of tissue smears for rapid diagnosis.
ambient ionization | MS imaging | multivariate statistics | pathology |
neurosurgery
MS is increasingly being used in medicine (e.g., in clinicalchemistry, pharmaceutical development, and proteomics).
Ambient ionization methods generate ions under atmospheric
conditions, with minimal to no sample preparation (1). De-
sorption electrospray ionization (DESI), an ambient method
that uses a spray of charged solvent as the projectile, provides
rapid chemical information while preserving tissue and cellular
morphology, allowing subsequent histopathology on the same
specimen (2). This feature allows integration of DESI-MS into
current workflows and postacquisition pathology. DESI-MS has
been used to study prostate cancer (3), bladder cancer (4), kidney
cancer (5), seminoma (6), lymphoma (7), gastrointestinal cancer
(8), and others. In each case, the recorded pattern of lipid signals
allows the differentiation of cancer from normal tissue. DESI-MS
has been previously used to explore chemical differences among
glioma subtypes, grades, and tumor cell concentrations (relative
percentage of tumor compared with parenchyma) (9, 10). Me-
ningiomas have also been studied previously and were distin-
guished from normal dura mater (11).
The incidence of brain tumors is approximately the same as
that of non-Hodgkin’s lymphoma, melanoma, and urinary bladder
cancer in adults over 20 y of age, and it is even more prevalent
among children. Gliomas (30%), meningiomas (33%), and pitui-
tary tumors (15%) account for the majority of brain tumors in
adults (12). The brain parenchyma is comprised of glia (e.g., as-
trocytes and oligodendrocytes) and neurons. In many cases, sur-
gical resection is the most effective treatment option; however,
surgery must contend with the dilemma of maximizing tumor ex-
cision while minimizing unintended neurological deficits. MRI, a
critical imaging method, aids in defining the location and size of
the tumor (13). The nuclear spin of hydrogen is exploited by MRI,
allowing visualization of different anatomical structures (e.g., T1-
weighted MRI) or pathologies (e.g., T2-weighted and contrast-
enhanced MRI). Additional information can be obtained by posi-
tron emission tomography, functional MRI, diffusion weighted
imaging, fluid-attenuated inversion recovery, and magnetic reso-
nance spectroscopic imaging (MRSI). Raman spectroscopy per-
formed in vivo seeks to provide chemical information that allows
rapid identification of cancerous tissue (14). Fluorescence imaging
uses appropriate molecular labels to visualize tumors during sur-
gery (15, 16). The information provided by these methods is used
primarily to visualize the tumor and assist in surgical resection.
Histopathology performed on frozen tissue sections and tissue
smears is the most common source of important pathologic in-
formation, specifically the type of tumor (e.g., glioma) and grade
(e.g., low grade), which is provided during surgery. This pathologic
analysis is often repeated for infiltrative tumors to guide the extent
of resection at the tumor margins. Currently, this information is
obtained outside of the operating room, taking upward of 20 min
per sample and prolonging surgery. Histopathology relies heavily
on morphologic and cytologic features revealed by staining of
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cellular structures (e.g., nucleus and cytoplasm). However, brain
tumors exhibit large genetic variability and genomic instability, which
remain invisible to microscope-based pathology. Auxiliary testing,
frequently immunohistochemistry or genetic sequencing, supports
pathologic diagnosis and has been used to estimate treatment re-
sponse (as in pharmacogenomics). Genetic testing remains time-
consuming [reporting of isocitrate dehydrogenase (IDH) mutation
status, a prognostic marker, can take weeks], creating delay in
pathologic diagnosis and rendering treatment. However, recently,
Shankar et al. (17) reported a genotyping method for IDH and
telomerase reverse transcriptase mutations, with results available
in 60 min.
Previous studies (3–11) have shown tissue discrimination by
mass spectral profiles (m/z values and associated abundances)
characteristic of different tissue types, including different disease
states. Rapid and direct analysis of tissue provides molecular
information on multiple compounds and is obtained on a time-
scale of seconds to a few minutes. In this way, ambient ionization
MS profiling stands in stark contrast to “-omics” techniques, which
are based on separation (e.g., liquid chromatography) before MS
and in which complex samples are extensively processed (e.g., by
desalting, extraction, and derivatization) to reveal, in detail, the
particular compounds present. Both the time required for analysis
and the complexity of high-performance hyphenated MS systems
mean that they are not amenable to intraoperative use.
The potential diagnostic value of using ambient ionization and
MS profiles, especially those based on lipids (18), is increasingly
being recognized as reflected by a growing number of studies.
Detection of metabolites by ambient ionization has also proven
useful in the detection of genetic mutations, such as IDH, but it
remains underexplored for potential diagnostic value. Differ-
ences in the lipid composition of renal cell carcinoma (19) and
colon cancer (20) from their respective normal parenchyma were
detected by positive ion probe electrospray ionization-MS. Touch
spray, a probe method allowing user-guided sampling, serves to
differentiate prostate cancer from normal tissue based on glycer-
ophospholipid distributions (3). Similar methods of ionization
have been used for the detection of lipids from lung (21) and brain
cancer (22). DESI-MS imaging of stereotactically registered brain
tumor samples (23) gave results that correlated with histopathol-
ogy and illustrated the potential for determining tumor cell con-
centration near the resection margins (10). The analysis of gastric
cancer surgical margins has been reported recently, including pixel
by pixel classification of heterogeneous tissue sections (8). Brain
and other cancers have been investigated using rapid evaporative
ionization-MS, a method that provides lipid-based differentiation
between cancerous and normal tissue and has been performed
in vivo on patients undergoing surgical resection with promising
results; however, electrocauterization is destructive and should
be used with discretion (24). Establishing a robust classification
method is of vital importance and best implemented by including
normal tissue. Obtaining normal tissue is particularly difficult in
the case of brain tumors, in which absolute normal rarely exists for
scientific study. Currently, intraoperative DESI-MS analysis is
limited by the need for freezing and cryosectioning before analysis;
therefore, we describe the use of tissue smears as a means to
quickly acquire differentiating chemical information. There is little
doubt that development of molecular techniques that rapidly dis-
criminate cancerous tissue would be of great benefit to supplement
intraoperative decision-making and pathologic evaluation.
Results and Discussion
DESI-MS Imaging of Human Brain Tissue Sections. We explore the
chemical information obtained from banked frozen brain tissue
sections by DESI-MS performed in the imaging mode. Negative
ionization DESI-MS images were recorded using different MS
tune methods consecutively from the same tissue section. The
main features of the MS profiles in the ranges m/z 200–1,000 and
m/z 80–200 were found to be associated with glycerophospholipids
and metabolites, respectively, and are referred to throughout as the
lipid and the metabolite profiles, respectively. These two MS pro-
files, containing many ions with relative abundances characteristic
of tissue type, were evaluated separately and also, together by
data fusion. Appropriate selection of the DESI-MS solvent allowed
acquisition of multiple images from the same tissue section while
preserving tissue morphology for subsequent histopathology, allow-
ing correlation of chemical, spatial, and pathologic information (2).
Differentiation of Gliomas and Brain Parenchyma. The chemical dif-
ferences between brain parenchyma and gliomas were explored by
comparing the molecular information obtained in the two MS
profiles and evaluating their ability in differentiating disease state
(i.e., normal vs. tumor). DESI-MS imaging revealed that gray and
white matter mass spectra differ and could be defined spatially (SI
Appendix, Fig. S1); however, areas of mixed composition were also
noted. Gray matter (Fig. 1A) is comprised of glia and mostly un-
myelinated neurons, and it is associated with a very abundant peak
at m/z 834 identified by high-resolution MS and MS/MS fragmen-
tation as phosphatidylserine (PS) with 40 carbons with 6 units of
unsaturation (40:6); predominant acyl chains are 18:0 (stearic acid)
and 22:6 (docosahexaenoic acid) as indicated by MS/MS (SI Ap-
pendix, Fig. S2). White matter (Fig. 1B) is characterized by an in-
creased relative abundance ofm/z 788 (PS 18:1–18:0), 888, 906, and
916. Sulfatides [e.g.,m/z 888; (3′-sulfo)GalCer 24:1] are particularly
abundant, which correlates with the increased myelination of neu-
rons. The pattern of ions that corresponded to gray and white
matter was consistent with previous studies of murine brain tissue
(25). The variations seen in the ratio of the signals associated with
m/z 834 and 888 do not compromise the differences in relative
abundance between gray and white matter (SI Appendix, Fig. S4).
Additional information on the identification of ions detected in the
lipid profile can be found in SI Appendix (SI Appendix, Figs. S2 and
S3 and Table S1). Differences in the lipid profiles were noted be-
tween anatomical regions of the brain, such as the molecular layer
of the cortex and the other cortical layers (e.g., in the specimen
shown in SI Appendix, Fig. S5). The m/z 788, 834, and 885 varied
between the molecular layer, which surrounds a meningeal blood
vessel (apparent in the ion image of m/z 788) and that of the cortex
itself. Furthermore, unsupervised multivariate analysis by in-
teractive brushing (26) supports the observed differences. Spe-
cific cases of special pathological or chemical interest like this
one are discussed throughout. The average mass spectrum for
gliomas (Fig. 1C) is very different from that of normal brain pa-
renchyma, in that it lacks the ions atm/z 834 and 888 characteristic
of gray and white matter, respectively. Rather, an increase in the
abundance of m/z 794 [chloride adduct of phosphatidylcholine
(PC) 34:1] and m/z 885 [phosphatidylinositol (PI) 18:0_20:4]
was noted.
Principal component analysis (PCA) was performed on the
lipid profiles selected from pathology-defined regions of brain
parenchyma and glioma tissue sections (Fig. 1 D and E). Gray
and white matters were well-separated based primarily on m/z
834 and 888, respectively. The dispersed locations of a few gray
and white matter points, those that fall between their respective
groupings, corresponded to tissue of mixed composition as reflected
in the mass spectra (SI Appendix, Fig. S6). This observation
reflects typical parenchyma composition, which contains a mixture
of unmyelinated and myelinated neurons as well as glial cells. Brain
parenchyma and glioma were well-separated in PCA space, indi-
cating that the first level of pathologic evaluation (is this a glioma
or brain parenchyma?) can be answered readily. Interestingly, the
glioma grouping was dispersed (Fig. 1D). Dispersion along the
vector of gray and white matter separation (right to left) is related
to the relative contribution of the parenchyma background to the
detected lipid profile. Specimen 42 (secondary infiltrated; with
∼40% tumor cell concentration) is illustrative of the juxtaposition
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of gray and white matter regions (SI Appendix, Figs. S7 and S8) and
the contribution of the background parenchyma to the lipid profile.
The differences between gray and white matter can overshadow
more subtle differences that indicate the presence of invasive tu-
mor cells. This observation does not preclude the differentiation of
normal tissue, infiltration, and gliomas but rather, confirms the
complexity associated with brain tumors. The dispersion of the
glioma class in the vertical direction in PCA score space (Fig. 1D)
reflects the extent of infiltration of tumor cells. A likely contribu-
tion to the observed dispersion of the glioma group is the presence
of glioma subtypes (e.g., astrocytoma and oligodendroglioma),
which are related to the glial cells from which the cancer is derived.
For example, the lipid profile of an oligodendroglioma might ap-
pear more similar to white matter, which is composed of a greater
number of oligodendrocytes than gray matter. Discrimination of
glioma subtypes has been previously studied (9) and is outside the
scope of this study. Note that subsequent histopathologic evalua-
tion revealed that normal specimens commonly contained various
levels of secondary infiltration. The gray and white matter classes
were comprised of regions containing <25% tumor cell concen-
tration (mode was 10%), and one sample contained 40% tumor
cell, representing a tissue composition that is reasonably expected
near the surgical margin. A few samples well-separated from the
glioma class in PCA space were considered completely normal and
found by the pathologist to contain no observable tumor cells
(<5%). Glioma points that fell between the glioma group and ei-
ther the gray or white matter group illustrate the disease spectrum
and the complexity in determining the disease state with contri-
butions of background parenchyma and infiltration.
The metabolite profile, acquired subsequent to the lipid profile,
has not been explored previously by DESI-MS in human brain tissue.
The average metabolite profile mass spectra obtained from gray
matter, white matter, and gliomas are displayed in Fig. 1 F–H, re-
spectively. The anion of lactic acid was detected atm/z 89 (identified
by exact mass measurements) (SI Appendix, Fig. S9 and Table S1)
and occurred in slightly increased abundance (128.9 ± 17.5%) in
gliomas vs. healthy tissue. This observation is consistent with meta-
bolic aberrations inherent in cancer (e.g., high rates of aerobic gly-
colysis) as postulated by Warburg (27), but it does not seem to be
uniquely predictive of disease. By contrast, a dramatic decrease in
m/z 174 was noted between gray and white matter and gliomas. A
box and whisker plot (Fig. 2A) indicated that m/z 174 alone allows
discrimination of brain parenchyma from glioma (Kruskal–Wallis
P value <0.001). Furthermore, a receiver-operating characteristic
curve of brain parenchyma and glioma resulted in an area under
the curve of 0.998 (SI Appendix, Fig. S10). Exact mass (Fig. 2B) and
MS/MS fragmentation obtained by collision-induced dissociation
(Fig. 2C) were used to identify m/z 174 as N-acetyl-aspartic acid
(NAA) detected as the deprotonated ion. The dramatic difference
between gray matter and glioma tissue is illustrated in specimen 51
(Fig. 2D). The intensities of m/z values 174, 794, 834, and 888 are
plotted from individual pixels noted in Fig. 2E over the transition
region from glioma to gray matter (Fig. 2F). The changes in the
lipid ions correctly reflect the regions indicated as glioma and brain
parenchyma by pathology (SI Appendix, Fig. S11). The change in
NAA is evident with a similar rate of change to the lipids near the
boundary of the two regions (approximately at pixel 12).
PCA was performed on the metabolite profile (Fig. 1 I and J)
and yielded poor separation of gray and white matter from each
other but clear separation between brain parenchyma and gli-
oma. The overwhelming significance of NAA in the multivariate
separation is notable. Interestingly, this finding supports previous
MRSI studies that indicated the significance of NAA in discrimi-
nating normal and diseased neural tissues (28, 29) and current use in
Fig. 1. Average lipid (m/z 700–1,000) and metabolite (m/z 80–200) MS profiles for gray matter (n = 223), white matter (n = 66), and glioma (n = 158) with PCA
score and loading plots. Average normalized [total ion chronogram (TIC)] lipid MS profile for (A) gray matter, (B) white matter, and (C) glioma. (D) PCA score plot
[principal component 1 (PC1) vs. principal component 2 (PC2)] using lipid profile information for gray matter (green circles), white matter (blue circles), and glioma
(red circles). (E) PCA loading plot withm/z annotated. Average metabolite MS profile for (F) gray matter, (G) white matter, and (H) glioma. (I) Metabolite profile
PCA score plot for gray matter, white matter, and glioma and (J) corresponding PCA loading plot.
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tumor diagnosis (13, 30). However, detection of NAA in situ by MS
has greater molecular specificity and speed compared with MRSI.
NAA is an abundant molecule in the human nervous system, the
biological function of which is still to be unraveled, but evidence
indicates a significant role in neural metabolism (31). Ties to central
metabolic processes can be made by aspartic acid as well as acetate,
including lipid metabolism, energy production, amino acid synthesis,
and gene regulation (31). Furthermore, NAA has been found to
decrease in many neurological diseases and disorders, such as
stroke, Alzheimer’s disease, epilepsy, and multiple sclerosis (31).
A reduction in the relative abundance of NAA was also noted in
specimens containing reactive matter (SI Appendix, Fig. S12); thus,
NAA seems to be an important measure of overall neural health.
2-Hydroxyglutaric acid (2HG; m/z 147) was also detected in
the metabolite profile in some of the glioma samples. 2HG is a
downstream metabolite of IDH mutations and serves as an im-
portant prognostic indicator (32, 33). The presence of m/z 147 in
specimen 51 was confirmed by MS/MS (SI Appendix, Fig. S13)
and found to correlate with the pathologically determined IDH
mutation status. The presence of m/z 147 in the metabolite
profile (full-scan mode) was indicative of 2HG presence, but
additional specificity and confirmation were achieved by MS/MS.
The detection of 2HG and its correlation with IDH mutation status
are outside the scope of this report, having been investigated pre-
viously (33). The ability to ascertain such information rapidly ex-
pands the value of DESI-MS methodology beyond tissue diagnosis.
The best separation of gray and white matter and glioma was
obtained when the lipid and metabolite profiles were considered
together using midlevel data fusion (SI Appendix, Fig. S14). Gray
matter (n = 223), white matter (n = 66), and gliomas (n = 158)
were well-separated and had little intraclass dispersion. PCA
followed by linear discriminant analysis (LDA) was performed to
estimate classification performance when fusing the two MS
profiles. The classification of gray matter, white matter, and
gliomas (SI Appendix, Table S2) had an overall sensitivity (i.e.,
measure of the proportion of positives that are correctly identified
as such) of 97.4% and a specificity (i.e., measure of the proportion
of negatives that are correctly identified as such) of 98.5%. The
methodology developed was further evaluated by predicting the
disease state and estimating the tumor cell concentration of a
pathologically ambiguous specimen (Fig. 3) as an external vali-
dation. A false-color plot of the PC1 scores of individual pixels
(SI Appendix, Fig. S15) revealed a region associated with glioma
(red pixels in Fig. 3A) and a region more closely associated with
white matter (blue pixels in Fig. 3A). Pathologic evaluation (Fig.
3B) of these two regions was ambiguous, with one clearly a glioma
and the other being either a diffuse glioma or an infiltrated region
adjacent to the tumor region, qualitatively matching our findings
of two chemically different regions. Additional evaluation was
performed using PCA LDA as shown in Fig. 3C, which classified a
region of glioma (on the right in Fig. 3C) while classifying the
adjacent region as white matter (on the left in Fig. 3C). The region
classified by LDA as white matter prompted additional examina-
tion for infiltration (because infiltration was not a part of the PCA
LDA model) by estimation of the tumor cell concentration. The
tumor cell concentration of each pixel (Fig. 3D) was calculated by
regression of a semilogarithmic plot of the natural log of NAA’s
TIC normalized abundance vs. tumor cell concentration (Pear-
son’s r = −0.89) (SI Appendix, Fig. S15). The estimated tumor cell
concentration in the glioma region was >75%, whereas the other
region had estimated concentrations ranging from ∼50% to 30%,
roughly matching with pathologic evaluation of 60%. This illus-
trative example supports that MS profiles, processed using mul-
tivariate statistics, can correctly discriminate gliomas and that they
can also be used to detect diffuse and infiltrative tumors, a par-
ticularly critical question during surgical resection.
Discrimination of Tumor Types. Meningiomas and pituitary tumors
represent a large fraction of all brain tumors; the lipid profile of
the former was explored in a previous study (11). We sought to
differentiate the tumor types investigated: glioma, meningioma,
and pituitary tumor. The average lipid mass spectra displayed
differences in the relative abundances of m/z 788, 794, and 885
between the tumor types (SI Appendix, Fig. S16). The metabolite
profile, previously discussed as being highly significant for glioma
discrimination, was less informative for meningiomas and pituitary
tumors, with small changes being noted in the average mass
spectra. PCA performed on glioma (n = 158), meningioma (n =
111), and pituitary tumors (n = 154) using the lipid information
Fig. 2. Statistical significance and identification of NAA. (A) Box and whisker plot form/z 174: gray matter (GM), n = 223; white matter (WM), n = 66; glioma
(G), n = 158; pituitary (P), n = 154; and meningioma (M), n = 111. The box represents the interquartile range with a median line and whiskers ±1.5 SD; outliers
are represented by open circles. (A, Inset) NAA. (B) Detection of NAA by high-resolution MS in (Upper) gray matter and (Lower) high-grade glioma in
specimen 51; m/z and resolution are annotated. (C) Collision-induced dissociation (CID) MS/MS fragmentation pattern obtained for NAA from gray matter in
specimen 51. (D) Plot of intensity change of select ions [m/z 174 (black), 794 (red), 834 (blue), and 888 (green)] occurring with the transition between high-
grade glioma and brain parenchyma in specimen 51. The pixels plotted in D (those of the horizontal scale bar) are indicated in the false-color image of a
summed set of ions (281, 303, 788, 834, 885, and 888) in E. (F) H&E image of specimen 51 with approximate location of pixels.
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provided good separation between all tumor types and was sup-
ported by PCA LDA estimation of sensitivity (99.4%) and speci-
ficity (99.7%) (SI Appendix, Table S3). Although remarkable, this
result is not surprising, because the cells and tissue from which the
various tumors arise are quite different (e.g., glia vs. meninges),
which is also reflected in histopathologic evaluation. The midlevel
fusion of metabolite and lipid profile information did not substantially
change the predicted classification. However, the average metabolite
MS for meningiomas indicated the lowest amounts of m/z 89 (lactic
acid) and 174 (NAA). In the case of NAA, the absence is supported by
previous NMR and liquid chromatography-MS studies (34), thus
serving as an endogenous positive control (i.e., signal neither expected
nor detected). DESI-MS ion images of specimen 20 (SI Appendix,
Fig. S17) illustrate the considerable difference between gray
matter and an invasive boundary of a meningioma. Differential
levels of NAA in gliomas, meningiomas, and pituitary tumors were
reported by MRSI, and our data support these previous findings
(29) (Fig. 2A). NAA signals were significantly different between
tumor types (P < 0.001), although the lack of significant change
(such as that observed between normal brain parenchyma and
glioma) limits the predictive value of NAA for discriminating
between tumor types. Comprehensively, lipid and metabolite
profiles subjected to PCA yielded separation of gliomas, menin-
giomas, and pituitary tumors with little ambiguity, suggesting that
an unknown sample from one of these three types of tumor could
be chemically recognized by the MS profiles.
DESI-MS Imaging and Characterization of Human Brain Tissue Smears.
DESI-MS analysis of tissue smears is an attractive alternative to
the use of tissue sections, removing the need for tissue freezing
and sectioning. To date, DESI-MS analysis of tissue and cyto-
logical smears has been only briefly explored (7, 33). Smears are
commonly performed by placing a minute amount of tissue onto
a glass slide and then physically spreading the material to achieve
a relatively uniform and diffuse layer of cellular material for
staining and subsequent pathology. Smears are typically made
using less than 50 mm3 tissue. A custom tissue smear device was
designed to confine the tissue to the middle of the glass slide
(along the narrowest dimension) and smear the tissue along the
longest dimension with an approximate thickness of 100 μm (SI
Appendix, Fig. S18).
Tissue smears were imaged over an area of ∼75 mm2, exploring
the MS quality and the homogeneity of the chemical information.
The absolute MS signal was generally equal to that of tissue sec-
tions. Importantly, the relative abundances of the ions were similar
between tissue sections and tissue smears. The average metabolite
and lipid profiles of gray matter and gliomas (SI Appendix, Fig.
S19) mirror those of the tissue sections. For example, the abun-
dance of m/z 834 is notable in the gray matter spectrum and
dramatically reduced in the gliomas. Similarly, the statistical sig-
nificance of NAA (m/z 174; P < 0.001) allows for the discrimi-
nation of gray matter and gliomas (SI Appendix, Fig. S20).
Canonical correlation analysis (CCA) (35) was performed to as-
sess the similarity of the chemical information obtained from tis-
sue smears and sections (SI Appendix, Fig. S21). The correlation
coefficients are notable (greater than 0.95) between the first three
canonical variables for both the lipid and metabolite profiles,
emphasizing that the physical change induced by smearing does
not influence the chemical information. As a precaution, it should
be mentioned that the sample matrix and associated analytical
effect could influence the data obtained by MS, but this effect was
not observed in our experiments. The lipid and metabolite profiles
of smears were nearly identical to those recorded from tissue
sections, indicating that sectioning can be foregone for more rapid
tissue smear analysis.
Conclusions
The application of DESI-MS in brain cancer resection requires
knowledge of the characteristic chemical features that distin-
guish brain parenchyma from glioma and different tumor types
from each other, and these differences are explored here for the
first time to our knowledge. The strategy of using MS profiles to
characterize tissue differs from the traditional use of biomarkers,
in which a single molecule (or ion detected by MS) is used as an
indicator of disease. MS profiles are an integrated representation
of downstream metabolism and provide important information
that extends beyond tissue diagnosis (e.g., in the case of 2HG
to prognosis).
In this study, we show that MS analysis of tissue sections revealed
lipid-derived and metabolite signals that differ between gray and
white matter and gliomas, facilitating discrimination by multivariate
statistics. Difference in the MS profiles revealed the effect of brain
parenchyma on the signal obtained from glioma samples. This
Fig. 3. DESI-MS predictions for specimen 65 and corresponding H&E. (A) PCA projection (false color) indicates PC1 score values. (B) H&E stain. (C) PCA LDA
prediction of class and (D) calculated tumor cell concentration based on NAA abundance.
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observation is particularly significant, because gliomas frequently
invade along white matter tracts, illustrating the need to understand
the contribution of brain parenchyma and infiltration in pre-
dicting disease state. The significance of NAA in discriminating
brain parenchyma and glioma is clear and immense. This study
offers strong evidence that NAA is, in fact, an oncometabolite and
the first in situ detection, to our knowledge, of NAA by ambient
MS. The importance of NAA in glioma differentiation confirms
nearly 20-y-old MRSI data. NAA also seems to be predictive of
tumor cell concentration in unknown samples with an exponential-
like decay in MS signal from brain parenchyma to glioma. Fusion
of the lipid and metabolite MS profiles provided the best dis-
crimination of brain parenchyma (gray and white matter) and
gliomas, with an overall sensitivity of 97.4% and a specificity of
98.5%. Furthermore, the MS profiles proved capable of discrim-
inating tumor types (i.e., glioma, meningiomas, and pituitary tu-
mors) with sensitivity and specificity >99%.
Surgical intervention of brain tumors could be simplified with
intraoperative analysis of tissue without extending operative times.
Tissue smears that eliminate the need for tissue freezing and
sectioning before DESI-MS were explored. The use of a custom
3D-printed smear device aided in the distribution of tissue during
smearing while maintaining a sufficiently thin smear for DESI-MS.
The observed lipid or metabolite profiles were not significantly
altered by the physical act of smearing, and their signal intensities
were comparable with those of tissue sections. Furthermore, the
chemical information obtained from tissue smears was equivalent
to that from tissue sections as determined by CCA. The validation
of tissue smears as samples for discriminate analysis remains to be
fully vetted; however, this work lays the foundation for imple-
mentation of DESI-MS intraoperatively.
Materials and Methods
Cryopreserved human neurological specimens were obtained from 74 pa-
tients (58 patients of whom were included in the sample cohort) through the
Biorepository of Methodist Research Institute. Tissue specimens were pre-
pared as tissue sections and tissue smears on glass microscope slides and
stored at −80 °C before analysis. MS measurements were performed on a
linear ion trap mass spectrometer (Finnigan LTQ; Thermo Electron Corpo-
ration). High-resolution MS measurements were performed using an Orbi-
trap Mass Spectrometer (Exactive, Thermo). DESI-MS was performed using
dimethylformamide-acetonitrile (1:1 vol/vol), which preserved tissue mor-
phology for subsequent pathology. Blind histopathologic evaluation was
performed by an expert pathologist. Sections and smears were subjected to
two sequential negative-mode DESI-MS image acquisitions (250-μm pixel
resolution). The first image included data fromm/z 200–1,000, with the mass
spectrometer tuned for maximum transmission of m/z 786. The moving
stage was then reset to the origin position, allowing for a subsequent image
was acquired from m/z 80–200 (MS tuned for m/z 174). Data were exported
from XCalibur 2.0 into .csv files, which were then imported into MATLAB. In-
house MATLAB routines were used to process all MS data unless otherwise
specified. Multivariate statistics, including PCA, midlevel data fusion PCA,
and CCA, were performed on the data. Kruskal–Wallis nonparametric test
was used to evaluate the statistical significance of NAA. Additional in-
formation and discussion of the materials and methods can be found in
SI Appendix.
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